These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 9485424

  • 1. The specificity of the N-terminal SH2 domain of SHP-2 is modified by a single point mutation.
    Huyer G, Ramachandran C.
    Biochemistry; 1998 Mar 03; 37(9):2741-7. PubMed ID: 9485424
    [Abstract] [Full Text] [Related]

  • 2. Alternative mode of binding to phosphotyrosyl peptides by Src homology-2 domains.
    Qin C, Wavreille AS, Pei D.
    Biochemistry; 2005 Sep 13; 44(36):12196-202. PubMed ID: 16142918
    [Abstract] [Full Text] [Related]

  • 3. Phosphopeptide ligands of the SHP-1 N-SH2 domain: effects on binding and stimulation of phosphatase activity.
    Hampel K, Kaufhold I, Zacharias M, Böhmer FD, Imhof D.
    ChemMedChem; 2006 Aug 13; 1(8):869-77. PubMed ID: 16902940
    [Abstract] [Full Text] [Related]

  • 4. Design and biological evaluation of linear and cyclic phosphopeptide ligands of the N-terminal SH2 domain of protein tyrosine phosphatase SHP-1.
    Imhof D, Wieligmann K, Hampel K, Nothmann D, Zoda MS, Schmidt-Arras D, Zacharias M, Böhmer FD, Reissmann S.
    J Med Chem; 2005 Mar 10; 48(5):1528-39. PubMed ID: 15743195
    [Abstract] [Full Text] [Related]

  • 5. Molecular dynamics simulations on the free and complexed N-terminal SH2 domain of SHP-2.
    Wieligmann K, Pineda De Castro LF, Zacharias M.
    In Silico Biol; 2002 Mar 10; 2(3):305-11. PubMed ID: 12542415
    [Abstract] [Full Text] [Related]

  • 6. Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584.
    Vogel W, Ullrich A.
    Cell Growth Differ; 1996 Dec 10; 7(12):1589-97. PubMed ID: 8959326
    [Abstract] [Full Text] [Related]

  • 7. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
    Wang LL, Blasioli J, Plas DR, Thomas ML, Yokoyama WM.
    J Immunol; 1999 Feb 01; 162(3):1318-23. PubMed ID: 9973385
    [Abstract] [Full Text] [Related]

  • 8. Peptidyl aldehydes as reversible covalent inhibitors of SRC homology 2 domains.
    Park J, Fu H, Pei D.
    Biochemistry; 2003 May 06; 42(17):5159-67. PubMed ID: 12718560
    [Abstract] [Full Text] [Related]

  • 9. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
    Eck MJ, Shoelson SE, Harrison SC.
    Nature; 1993 Mar 04; 362(6415):87-91. PubMed ID: 7680435
    [Abstract] [Full Text] [Related]

  • 10. Mutational investigation of the specificity determining region of the Src SH2 domain.
    Bradshaw JM, Mitaxov V, Waksman G.
    J Mol Biol; 2000 Jun 02; 299(2):521-35. PubMed ID: 10860756
    [Abstract] [Full Text] [Related]

  • 11. Mechanistic studies on full length and the catalytic domain of the tandem SH2 domain-containing protein tyrosine phosphatase: analysis of phosphoenzyme levels and Vmax stimulatory effects of glycerol and of a phosphotyrosyl peptide ligand.
    Wang J, Walsh CT.
    Biochemistry; 1997 Mar 11; 36(10):2993-9. PubMed ID: 9062130
    [Abstract] [Full Text] [Related]

  • 12. Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate.
    Hoedemaeker FJ, Siegal G, Roe SM, Driscoll PC, Abrahams JP.
    J Mol Biol; 1999 Oct 01; 292(4):763-70. PubMed ID: 10525402
    [Abstract] [Full Text] [Related]

  • 13. Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors.
    Burshtyn DN, Lam AS, Weston M, Gupta N, Warmerdam PA, Long EO.
    J Immunol; 1999 Jan 15; 162(2):897-902. PubMed ID: 9916713
    [Abstract] [Full Text] [Related]

  • 14. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
    Godeny MD, Sayyah J, VonDerLinden D, Johns M, Ostrov DA, Caldwell-Busby J, Sayeski PP.
    Cell Signal; 2007 Mar 15; 19(3):600-9. PubMed ID: 17027227
    [Abstract] [Full Text] [Related]

  • 15. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY, Waksman G.
    J Mol Biol; 2002 Feb 15; 316(2):291-304. PubMed ID: 11851339
    [Abstract] [Full Text] [Related]

  • 16. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM, Mitaxov V, Waksman G.
    J Mol Biol; 1999 Nov 05; 293(4):971-85. PubMed ID: 10543978
    [Abstract] [Full Text] [Related]

  • 17. Dual specificity of Src homology 2 domains for phosphotyrosine peptide ligands.
    Gay B, Furet P, García-Echeverría C, Rahuel J, Chène P, Fretz H, Schoepfer J, Caravatti G.
    Biochemistry; 1997 May 13; 36(19):5712-8. PubMed ID: 9153411
    [Abstract] [Full Text] [Related]

  • 18. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G, Davis B, Kristensen SM, Sankar A, Linacre J, Stein RC, Panayotou G, Waterfield MD, Driscoll PC.
    J Mol Biol; 1998 Feb 20; 276(2):461-78. PubMed ID: 9512716
    [Abstract] [Full Text] [Related]

  • 19. Decoding protein-protein interactions through combinatorial chemistry: sequence specificity of SHP-1, SHP-2, and SHIP SH2 domains.
    Sweeney MC, Wavreille AS, Park J, Butchar JP, Tridandapani S, Pei D.
    Biochemistry; 2005 Nov 15; 44(45):14932-47. PubMed ID: 16274240
    [Abstract] [Full Text] [Related]

  • 20. A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail.
    Poole AW, Jones ML.
    Cell Signal; 2005 Nov 15; 17(11):1323-32. PubMed ID: 16084691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.